Episode 32: Hormones, Power & Productivity: The Menopause Conversation Corporate America Is Avoiding

Women are leaving boardrooms, launching businesses, caring for aging parents, and managing teenagers, all while their biology is shifting beneath them. And instead of education, they receive dismissal. Instead of data, they receive shame. Instead of solutions, they receive “this is just aging.”

If women will spend one-third of their lives in postmenopause, why are we still treating it like a footnote?

In this episode, all three voices return to examine midlife through the lens of biology and leadership:

• Jennifer Gularson breaks down perimenopause, menopause, hormone myths, and longevity science.

• Lisa Schneider shares how hormone literacy shifts women’s confidence and decision-making inside Pearl & Rose communities.

• Samantha McDaniel reflects on how hormonal health intersects with long-term cognitive wellness and aging.

We confront the economic reality that menopause symptoms cost U.S. businesses billions annually, yet remain under-discussed in leadership spaces. We unpack:

• The myths we’ve inherited

• The truth about hormone replacement therapy

• Why so many women are misdiagnosed with anxiety or depression

• The professional consequences of unmanaged symptoms

• Energy, libido, sleep, brain fog, and leadership performance

To be clear, this is not a wellness episode. It is a leadership episode.